Potential of nutrigenetics in the treatment of metabolic disorders

References

• Farooqi IS, Matarese G, Lord GM et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J. Clin. Invest.110(8), 1093–1103 (2002).
   PubMed Web of Science ®Google Scholar
• Feero WG, Guttmacher AE, Collins FS. The genome gets personal – almost. JAMA299(11), 1351–1352 (2008).
   PubMed Web of Science ®Google Scholar
• Levy S, Sutton G, Ng PC et al. The diploid genome sequence of an individual human. PLoS Biol5(10), e254 (2007).
   PubMed Web of Science ®Google Scholar
• Janssens AC, van Duijn CM. Towards predictive genetic testing of complex diseases. Eur. J. Epidemiol.21(12), 869–870 (2006).
   PubMedGoogle Scholar
• Janssens AC, Aulchenko YS, Elefante S, Borsboom GJ, Steyerberg EW, van Duijn CM. Predictive testing for complex diseases using multiple genes: fact or fiction? Genet. Med.8(7), 395–400 (2006).
   PubMed Web of Science ®Google Scholar
• Ordovas JM, Mooser V. Nutrigenomics and nutrigenetics. Curr. Opin. Lipidol.15, 101–108 (2004).
   PubMed Web of Science ®Google Scholar
• Mutch DM, Wahli W, Williamson G. Nutrigenomics and nutrigenetics: the emerging faces of nutrition. FASEB J.19, 1602–1616 (2005).
   PubMed Web of Science ®Google Scholar
• Marima ECM. Nutrigenomics and nutrigenetics: the “omics” revolution in nutritional science. Biotechnol. Appl. Biochem.44, 119–128 (2006).
   PubMedGoogle Scholar
• Helgadottir A, Manolescu A, Helgason A et al. A variant of the gene encoding leukotriene A4 hydrolase confers ethnic-specific risk of myocardial infarction. Nat. Genet.38(1), 68–74 (2006).
   PubMed Web of Science ®Google Scholar
• Ordavos JM. Gender, a significant factor in the cross talk between genes, environment, and health. Gend. Med.4(Suppl. B), S111–S121 (2007).
   Google Scholar
• Altmüller J, Palmer LJ, Fischer G, Scherb H, Wjst M. Genomewide scans of complex human diseases: true linkage is hard to find. Am. J. Hum. Genet.69, 936–950 (2001).
   PubMedGoogle Scholar
• Elbein SC. Perspective: the search for genes for Type 2 diabetes in the post-genomics era. Endocrinol.143(6), 2012–2018 (2002).
   PubMedGoogle Scholar
• Baier LJ, Hanson RL. Genetics studies of the etiology of Type 2 diabetes in Pima Indians – hunting for pieces of a complicated puzzle. Diabetes53, 1181–1186 (2004).
   PubMedGoogle Scholar
• Freimer NB, Sabatti C. Human genetics: variants in common diseases. Nature445(7130), 828–830 (2007).
   PubMedGoogle Scholar
• Frayling TM, Timpson NJ, Weedon MN et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science316(5826), 889–894 (2007).
   PubMed Web of Science ®Google Scholar
• Loos RJF, Lindgren CM, Li S et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat. Genet.40(6), 768–775 (2008).
   PubMed Web of Science ®Google Scholar
• Farooqi IS, Yeo GS, Keogh JM et al. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J. Clin. Invest.106(2), 271–279 (2000).
   PubMed Web of Science ®Google Scholar
• Arkadianos I, Valdes AM, Marinos E, Florou A, Gill RD, Grimaldi KA. Improved weight management using genetic information to personalize a calorie controlled diet. Nutr. J.6, 29 (2007).
   PubMed Web of Science ®Google Scholar
• Manolio TA, Brooks LD, Collins FS. A HapMap harvest of insights into the genetics of common disease. J. Clin. Invest.118(5), 1590–1605 (2008).
   PubMed Web of Science ®Google Scholar
• Willer CJ, Sanna S, Jackson AU et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat. Genet.40(2), 161–169 (2008).
   PubMed Web of Science ®Google Scholar
• Zeggini E, Scott LJ, Saxena R et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat. Genet.40(5), 638–645 (2008).
   PubMed Web of Science ®Google Scholar
• Guan W, Pluzhnikov A, Cox NJ et al. Meta-analysis of 23 Type 2 diabetes linkage studies from the International Type 2 Diabetes Linkage Analysis Consortium. Hum. Hered.66(1), 35–49 (2008).
   PubMedGoogle Scholar
• Stoehr JP, Nadler ST, Schueler KL et al. Genetic obesity unmasks nonlinear interactions between murine Type 2 diabetes susceptibility loci. Diabetes49, 1946–1954 (2000).
   PubMedGoogle Scholar
• Leiter EH, ReifsynderPC, Flurkey K, Partke H-J, Junger E, Herberg L. NIDDM genes in mice: deleterious synergism by both parental genomes contributes to diabetogenic thresholds. Diabetes47(8), 1287–1295 (1998).
   PubMed Web of Science ®Google Scholar
• Scriver CR, Kaufman S. Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. In: The Metabolic and Molecular Bases of Inherited Disease (Volume 2). Scriver CR, Beaudet AL, Sly WS, Valle D (Eds). McGraw-Hill, NY, USA 1667–1724 (2001).
   Google Scholar
• Scriver CR, Waters PJ. Monogenic traits are not simple: lessons from phenylketonuria. Trends Genet.15(7), 267–272 (1999).
   PubMed Web of Science ®Google Scholar
• Kutz G. Nutrigenetic testing: tests purchased from four web sites mislead consumers. GAO-06–977T, United States Government Accountability Office, Washington, DC, USA (2006).
   Google Scholar
• Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolemia. In: The Metabolic and Molecular Bases of Inherited Disease (Volume 2). Scriver CR, Beaudet AL, Sly WS, Valle D (Eds). McGraw-Hill, NY, USA, 2863–2913 (2001).
   Google Scholar
• Janssens AC, Gwinn M, Bradley LA, Oostra BA, van Duijn CM, Khoury MJ. A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions. Am. J. Hum. Genet.82, 593–599 (2008).
   PubMed Web of Science ®Google Scholar
• Werman A, Hollenberg A, Solanes G, Bjorbaek C, Vidal-Puig AJ, Flier JS. Ligand-independent activation domain in the N-terminus of peroxisome proliferator-activated receptor γ (PPAR-γ). Differential activity of PPARγ1 and 2 isoforms and influence of insulin. J. Biol. Chem.272(32), 20230–20235 (1997).
   PubMed Web of Science ®Google Scholar
• Ristow M, Müller-Wieland D, Pfeiffer A, Krone W, Kahn CR. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. N. Engl. J. Med.339(14), 953–959 (1998).
   PubMed Web of Science ®Google Scholar
• Barroso I, Gurnell M, Crowley VEF et al. Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension. Nature402(6764), 880–883 (1999).
   PubMed Web of Science ®Google Scholar
• Savage DB, Tan GD, Acerini CL et al. Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-γ. Diabetes52(4), 910–917 (2003).
   PubMed Web of Science ®Google Scholar
• Memisoglu A, Hu FB, Hankinson SE et al. Interaction between a peroxisomal proliferator-activated receptor γ gene polymorphism and dietary fat intake in relation to body mass. Hum. Mol. Genet.12, 2923–2929 (2003).
   PubMed Web of Science ®Google Scholar
• Semple RK, Chatterjee VK, O’Rahilly S. PPARγ and human metabolic disease. J. Clin. Invest.116(3), 581–589 (2006).
   PubMed Web of Science ®Google Scholar
• Meirhaeghe A, Amouyel P. Impact of genetic variation of PPARγ in humans. Mol. Genet. Metab.83(1–2), 93–102 (2004).
   PubMed Web of Science ®Google Scholar
• Wald DS, Wald NJ, Morris JK, Law M. Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence. BMJ333(7578), 1114–1117 (2006).
   PubMed Web of Science ®Google Scholar
• Lonn E, Yusif S, Arnold MJ et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N. Engl. J. Med.354(15), 1567–1577 (2006).
   PubMed Web of Science ®Google Scholar
• Bailey LB, Gregory JF. Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. J. Nutr.129(5), 919–922 (1999).
   PubMed Web of Science ®Google Scholar
• Frosst P, Blom HJ, Milos R et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet.10, 111–113 (1995).
   PubMed Web of Science ®Google Scholar
• Malinow MR, Nieto FJ, Kruger WD et al. The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes. Arterioscler. Thromb. Vasc. Biol.17(6), 1157–1162 (1997).
   PubMed Web of Science ®Google Scholar
• Nelen WLDM, Blom HJ, Thomas CMG et al. Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages. J. Nutr.128(8), 1336–1341 (1998).
   PubMedGoogle Scholar
• Brattström L, Wilcken DE, Ohrvik J, Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation98(23), 2520–2526 (1998).
   PubMed Web of Science ®Google Scholar
• Gudnason V, Stansbie D, Scott J, Bowron A, Nicaud V, Humphries S. C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): its frequency and impact on plasma homocysteine concentration in different European populations. EARS group. Atherosclerosis136(2), 347–354 (1998).
   PubMed Web of Science ®Google Scholar
• Bonna KH, Njolstad I, Ueland PM et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N. Engl. J. Med.354(15), 1578–1588 (2006).
   PubMedGoogle Scholar
• Ordovas JM, Corella D, Demissie S et al. Dietary fat intake determines the effect of a common polymorphism in the hepatic lipase gene promoter on high-density lipoprotein metabolism: evidence of a strong dose effect in this gene–nutrient interaction in the Framingham Study. Circulation106, 2315–2321 (2002).
   PubMed Web of Science ®Google Scholar
• Ordovas JM, Corella D, Cupples LA et al. Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL-cholesterol concentrations in a sex-specific manner: the Framingham Study. Am. J. Clin. Nutr.75, 38–46 (2002).
   PubMed Web of Science ®Google Scholar